Antenatal steroid therapy before 33 weeks' gestation

Area of Science:

• Obstetrics and Gynecology
• Neonatal Medicine
• Perinatal Research

Background:

• Antenatal steroid administration is crucial for fetal lung maturation in preterm births.
• Contemporary patterns of antenatal steroid use in pregnancies before 33 weeks gestation require investigation.
• Understanding factors influencing steroid administration is key to optimizing perinatal outcomes.

Purpose of the Study:

• To identify factors affecting antenatal steroid use in pregnancies delivered before 33 weeks gestation.
• To evaluate the clinical circumstances surrounding steroid treatment decisions in preterm births.
• To inform guidelines for antenatal steroid administration in high-risk pregnancies.

Main Methods:

• Retrospective analysis of 86 consecutive patients delivering before 33 weeks gestation.
• Comparison of clinical factors between 20 women receiving antenatal dexamethasone and 66 untreated cases.
• Assessment of risk factors, membrane status, labor characteristics, and delivery intervals.

Main Results:

• Traditional preterm birth risk factors did not differentiate between treated and untreated groups.
• Premature rupture of membranes and documented preterm labor were more frequent in the untreated cohort (P < 0.01).
• A significant proportion of untreated patients could have received a full course of steroids if delivery was delayed.

Conclusions:

• Many preterm births are unpredictable, challenging timely steroid administration.
• Universal antenatal steroid treatment is suggested for all women with preterm labor before 33 weeks gestation.
• Reevaluation of steroid use in cases of premature rupture of membranes and early gestational age (24-28 weeks) is warranted.